Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
29°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
215.63
-0.71 (-0.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biogen Idec
< Previous
1
2
3
4
5
Next >
Biogen and Happify Health Collaborate to Support Multiple Sclerosis Patients on Digital Platform
June 22, 2022
From
Happify Health
Via
Business Wire
NASDAQ:BIIB Long Term Investor Alert: Investigation of Potential Wrongdoing at Biogen Inc.
June 10, 2022
San Diego, CA -- (SBWIRE) -- 06/10/2022 -- Certain directors of Biogen Inc. are under investigation over possible breaches of fiduciary duties.
Via
SBWire
Rising Cases Of Mental Health Disorders of Stress, Anxiety & Addiction Fueling Need for Central Nervous System Therapeutics
June 07, 2022
Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – The global Central Nervous System (CNS) treatments and its market revenues had been steadily growing pre-pandemic and are still...
Via
FinancialNewsMedia
Exposures
COVID-19
Biogen Leads From the Top With Disability Inclusion
December 03, 2021
SOURCE: Biogen
Via
3BL Media
From Pause to Pride: A Mother's Journey
December 01, 2021
SOURCE: Biogen
Via
3BL Media
Topics
LGBTQ
Exposures
Diversity
Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis
May 05, 2022
From
MedRhythms
Via
Business Wire
Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Zuranolone for the Potential Treatment of Major Depressive Disorder (MDD)
May 02, 2022
From
Sage Therapeutics, Inc.
Via
Business Wire
Biogen Inc. (NASDAQ:BIIB) Investor Notice: Deadline in Lawsuit on April 8, 2022
March 28, 2022
San Diego, CA -- (SBWIRE) -- 03/28/2022 -- The Shareholders Foundation announced that a deadline is coming up on April 8, 2022 in the lawsuit filed for certain investors of Biogen Inc. (NASDAQ:BIIB).
Via
SBWire
Introducing Biogen's 2021 Diversity, Equity & Inclusion Report
November 04, 2021
SOURCE: Biogen
Via
3BL Media
Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally
February 24, 2022
Palm Beach, FL –– February 24, 2022 – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially but the development of novel medications has not kept...
Via
FinancialNewsMedia
Exposures
COVID-19
NASDAQ:BIIB Investor Alert: Lawsuit Alleges Misleading Statements by Biogen Inc.
February 23, 2022
San Diego, CA -- (SBWIRE) -- 02/23/2022 -- An investor, who purchased NASDAQ:BIIB shares, filed a lawsuit against Biogen Inc over alleged Securities Laws violations.
Via
SBWire
BIIB Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Biogen, Inc. Investors of Class Action and Encourages Investors to Contact the Firm
February 14, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Biogen Update
February 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Biogen Class Action Reminder
February 12, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BIIB Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Biogen, Inc. Investors of Class Action and Encourages Investors to Contact the Firm
February 11, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Shareholder Alert: Robbins LLP Reminds Investors Biogen, Inc. (BIIB) is Being Sued for Misleading Shareholders
February 11, 2022
From
Robbins LLP
Via
Business Wire
Biogen Shareholder Notice
February 10, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
BIOGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Biogen, Inc. and Encourages Investors to Contact the Firm
February 09, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Biogen Shareholder Alert
February 09, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
CORRECTING and REPLACING Shareholder Alert: Robbins LLP Informs Investors Biogen, Inc. (BIIB) is Being Sued for Misleading Shareholders
February 09, 2022
From
Robbins LLP
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors Biogen, Inc. (BIIB) is Being Sued for Misleading Shareholders
February 09, 2022
From
Robbins LLP
Via
Business Wire
Biogen Deadline Alert
February 08, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sage Therapeutics and Biogen Announce New Analyses from the LANDSCAPE Clinical Development Program of Zuranolone in MDD Presented at the American College of Neuropsychopharmacology (ACNP) Congress
December 08, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Sage Therapeutics and Biogen Announce Positive, One-Year Zuranolone 50 mg Data in the Ongoing Open-Label SHORELINE Study in Patients with MDD
December 01, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Youth Neurology Program: Building a More Diverse Neurology Workforce
November 30, 2021
SOURCE: Biogen
Via
3BL Media
Exposures
COVID-19
Wanda Castro-Borrero: Carrying on Legacy of Care
November 23, 2021
SOURCE: Biogen
Via
3BL Media
Topics
LGBTQ
Exposures
Diversity
Biogen Sets Industry Record with Recognition on Dow Jones Sustainability World Index for 9th Consecutive Year
November 15, 2021
SOURCE: Biogen
Via
3BL Media
Topics
Climate Change
Stocks
Supply Chain
Exposures
COVID-19
Climate
Supply Chain
Global Cancer Therapy Market Expected to Reach $268 Billion In 2026, With A CAGR Of 9.15%
November 16, 2021
Palm Beach, FL –November 16, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has affected the healthcare systems globally and also has a significant impact on the cancer therapy...
Via
FinancialNewsMedia
Exposures
COVID-19
CEO Climate Alliance to World Leaders: We Support You in Taking Decisive Climate Steps at COP26
November 11, 2021
SOURCE: Biogen
Via
3BL Media
Topics
Emissions
Biogen Launches Supplier Climate Action Program “Energize” With Leading Pharmaceutical Companies
November 04, 2021
SOURCE: Biogen
Via
3BL Media
Topics
Climate Change
Supply Chain
Exposures
Climate
Supply Chain
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.